GlaxoSmithKline announced the results of a Phase III study of its HPV vaccine, Cervarix, which showed that two doses of the vaccine in girls aged 9 to 14 years provide an immunogenicity matching the ...

WASHINGTON (Reuters) - GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in ...

December 3, 2009 — The Cervarix vaccine, manufactured by GlaxoSmithKline, provides a high level of long-term protection against human papillomavirus (HPV) types 16 and 18. According to new data ...

The pursuit to become the top-selling cervical cancer vaccine intensified last week as GlaxoSmithKline submitted its Biologics License Application (BLA) for Cervarix with the FDA. Cervarix is being ...

LONDON, April 17 (Reuters) - GlaxoSmithKline Plc's experimental vaccine Cervarix, designed to protect women against a virus that causes cervical cancer, has proved effective for up to 5-1/2 years, ...

Two doses of the HPV-16/18 AS04-adjuvanted vaccine Cervarix (GlaxoSmithKline) are non-inferior to three-doses in the current schedule, research shows. Since high coverage and compliance rates can be ...

GlaxoSmithKline's Cervarix may have been the first HPV shot approved in mainland China, but Merck's Gardasil now has an opening to gain the lead. Cervarix hasn't launched yet in the country, and as of ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Centers for Disease Control and Prevention’s Advisory Committee on ...

Cervical cancer is the fourth commonest cause of cancer among women, and tragically is often diagnosed too late. It is caused by the human papillomavirus (HPV) which is easily spread by sexual ...

September 30, 2009 (updated October 1, 2009) — The sudden death of a 14-year-old British girl shortly after she received Cervarix, a vaccine against human papillomavirus (HPV) to prevent cervical ...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cervarix Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's offering.

Amanda Steele first noticed a change in her daughter Carly last summer. The normally exuberant 13-year-old had lost all of her energy. Whereas normally she would have spent her days outside on the ...